North America Archives - Page 13 of 39 - Journal for Clinical Studies

Current Edition

Europe

United Therapeutics tosses out esuberaprost after trial flop

This comes as United Therapeutics has been doing a series of pacts and buyouts amid generic competition. (Bryan Brandenburg/CC by-SA 3.0) United Therapeutics is ...

8 April 2019 Europe | news | North America | Regional News

Continue Reading →

news

Pfizer wins expanded Ibrance approval using real world data

Pfizer on Thursday secured an expanded U.S. approval for its breast cancer drug Ibrance to men, relying not on clinical study but rather on data from electronic heal...

8 April 2019 news | North America | Regional News

Continue Reading →

Europe

No return for the Merrimack

Merrimack Pharmaceuticals is shelving yet another lead candidate after a review of Phase 1 safety data found the drug wasn't going to meet an "optimal therapeutic in...

8 April 2019 Europe | news | North America | Regional News

Continue Reading →

news

Myoderm Executive Leadership Announcement

CEO Michael Cohen to become Executive Chairman; COO James Lovett to be promoted to CEO Norristown, PA, April 2, 2019 -- Myoderm, a global clinical trial supply co...

5 April 2019 news | North America | Regional News

Continue Reading →

news

Allergan eye drug fails to impress on safety, upping pressure ahead of key meeting

Allergan on Tuesday disclosed new safety results for an experimental eye drug, abicipar, but a modest improvement in a key inflammation rate failed to convince Wall ...

4 April 2019 news | North America | Regional News

Continue Reading →

news

Dementia: Amyloid PET scans can improve diagnosis and care

PET scans that can detect changes in the brain relating to Alzheimer's disease could improve the diagnosis and medical care of people with dementia and similar sympt...

4 April 2019 news | North America | Regional News

Continue Reading →

news

Early pancreatic cancer data give Clovis a new path in PARP market

Early Phase 2 data suggest Clovis Oncology's targeted cancer drug Rubraca may work as a maintenance therapy for certain pancreatic cancer patients, according to a st...

4 April 2019 news | North America | Regional News

Continue Reading →

news

Selumetinib granted US Breakthrough Therapy Designation in neurofibromatosis type 1

AstraZeneca and MSD, Inc., Kenilworth, NJ, US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced that the US Food and Drug Administration...

4 April 2019 news | North America | Regional News

Continue Reading →

news

Triphase Accelerator Initiates Phase 1 Clinical Trial of TRPH-222 in B-cell Lymphoma

Next Generation Antibody-Drug Conjugate Developed Using Catalent’s SMARTag® ADC Technology Toronto, Ontario, and Somerset, N.J. – April 1, 2019 – Triphase Acc...

1 April 2019 news | North America | Regional News

Continue Reading →

news

FDA warns doctors, myeloma patients of doubled death risk from AbbVie, Roche’s Venclexta

Trial patients receiving benefit from Venclexta can continue taking the drug, the FDA said. (AbbVie) Earlier this month, the FDA halted enrollment in multiple my...

28 March 2019 news | North America | Regional News

Continue Reading →